LL-37 Peptide Research
LL-37 is a human antimicrobial peptide with a legitimate role in innate immunity and host defense.
immune peptide
Early Clinical
research maturity
Overview
LL-37 is a human antimicrobial peptide with a legitimate role in innate immunity and host defense. Unlike many wellness peptides, it originates from a well-recognized biologic function in barrier defense and immunomodulation.
Comparisons
Related stacks
Immunity Stack
Inflammation Stack
Mechanism
LL-37 disrupts microbial membranes and also participates in immune signaling, inflammation, and tissue-repair responses. That dual role is part of why it is scientifically interesting and clinically nuanced.
Clinical interest
Clinical interest centers on host defense, immune resilience, antimicrobial biology, and wound or tissue response. It should be discussed as a complex immune peptide rather than as a simplistic ‘immunity booster.’
Research summary
The evidence includes host-defense reviews, experimental immunology, and modern discussions of LL-37 in inflammation and autoimmunity. The literature supports real biologic relevance, but therapeutic use remains context-dependent and not straightforward.
Safety considerations
Because LL-37 can participate in both protective and inflammatory processes, more is not automatically better. The nuance of immune context matters, and communication should avoid reducing it to broad wellness language.
Key information
Research stage
Early Clinical
Evidence rating
Moderate
Search intent
informational
Last review
Mar 13, 2026
Featured studies
(
6
)
Frequently asked questions
What is LL-37?
LL-37 is a human antimicrobial host-defense peptide involved in innate immunity, barrier protection, and immune signaling.
Is LL-37 simply an antimicrobial peptide?
No. It also has broader roles in inflammation, autoimmunity, and tissue-repair signaling, which is why it must be interpreted carefully.